首页 | 官方网站   微博 | 高级检索  
     


Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
Authors:F Nelli  A Fabbri  A Onorato  D Giannarelli  MA Silvestri  G Pessina  JR Giron Berrios  A Virtuoso  E Marrucci  M Schirripa  M Mazzotta  V Panichi  P Cercola  C Signorelli  MG Chilelli  F Primi  EM Ruggeri
Affiliation:1. Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy;2. Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy;3. Department of Oncology and Hematology, Microbiology and Virology Unit, Central Hospital of Belcolle, Viterbo, Italy;4. Department of Oncology and Hematology, Molecular Biology and Covid Diagnostics, Central Hospital of Belcolle, Viterbo, Italy
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号